Anticoagulants and fibrinolytic drugs

被引：0
作者：
Sneader, W [1 ]
机构：
[1] UNIV STRATHCLYDE, GLASGOW G1 1XQ, LANARK, SCOTLAND
来源：
DRUG NEWS & PERSPECTIVES | 1997年 / 10卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：494 / 500
页数：7
相关论文
共 50 条
[31]   Thrombin activatable fibrinolytic inhibitor (TAFI) is upregulated in patient populations: Effects of anticoagulants [J].
Florian-Kujawski, M ;
Hoppensteadt, D ;
Kereiakes, D ;
Lewis, B ;
Fareed, J .
LABORATORY INVESTIGATION, 2003, 83 (01) :53A-53A
[32]   Natural anticoagulants and fibrinolytic activity following interferon therapy in chronic viral hepatitis [J].
Al Ghumlas, Abeer Khalid ;
Gader, Abdel Galil Mohammed Abdel ;
Al Faleh, Faleh Zaid .
BLOOD COAGULATION & FIBRINOLYSIS, 2008, 19 (04) :263-267
[33]   Thrombin activatable fibrinolytic inhibitor (TAFI) is upregulated in patient populations: Effects of anticoagulants [J].
Florian-Kujawski, M ;
Hoppensteadt, D ;
Kereiakes, D ;
Lewis, B ;
Fareed, J .
MODERN PATHOLOGY, 2003, 16 (01) :53A-53A
[34]   New antiplatelet drugs and new oral anticoagulants [J].
Koenig-Oberhuber, V. ;
Filipovic, M. .
BRITISH JOURNAL OF ANAESTHESIA, 2016, 117 :74-84
[35]   Hypersensitivity Reactions to modern Antiplatelet Drugs and Anticoagulants [J].
Hofmeier, Kathrin Scherer ;
Bircher, Andreas J. .
ALLERGO JOURNAL, 2015, 24 (02) :32-40
[36]   ASPECTS OF MULTIPLE BINDING OF ANTICOAGULANTS AND OTHER DRUGS [J].
WOSILAIT, WD .
GENERAL PHARMACOLOGY, 1977, 8 (01) :7-12
[37]   INTERACTIONS OF ORAL COUMARIN ANTICOAGULANTS WITH OTHER DRUGS [J].
SANDLER, AI .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1970, 4 (06) :146-&
[38]   Conundrums in the combined use of anticoagulants and antiplatelet drugs [J].
Schneider, David J. ;
Sobel, Burton E. .
CIRCULATION, 2007, 116 (03) :305-315
[39]   Anticoagulants and antiplatelet drugs during cataract surgery [J].
Kara-Junior, Newton ;
Koch, Camila Ribeiro ;
de Santhiago, Marcony Rodrigues ;
Fornari, Luciana ;
Caramelli, Bruno .
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2018, 81 (04) :348-353
[40]   Thrombolytic (fibrinolytic) drugs and progress in treating cardiovascular disease [J].
不详 .
FASEB JOURNAL, 2005, 19 (06) :671-671
12345